风光股份 reported revenue of ¥0.52B for the period ended 2026-06-30, -5.5% year on year. Net income was ¥-0.02B, a -4.0% net margin on a 11.2% gross margin. The largest revenue line is 集成助剂 at 60% of the total. Free cash flow for the period was ¥-0.04B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.52B | -5.5% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 11.2% | Net margin -4.0% |
| Revenue Q/Q | -12.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 集成助剂 | ¥0.31B | 59.8% |
| 单剂 | ¥0.18B | 34.2% |
| 其他主营业务 | ¥0.03B | 5.9% |
| 其他(补充) | ¥0.00B | 0.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.46B | 88.8% |
| R&D | ¥0.02B | 3.9% |
| SG&A | ¥0.06B | 10.7% |
| Tax & other | ¥0.00B | 0.7% |
| Item | Amount |
|---|---|
| Total assets | ¥2.39B |
| Total liabilities | ¥0.37B |
| Shareholders' equity | ¥2.02B |
| Equity / assets | 84.4% |
| Operating cash flow | ¥-0.03B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.04B |
| Cash conversion (OCF / net income) | 369% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
明月镜片 ・ 兆讯传媒 ・ 何氏眼科 ・ 鸿铭股份 ・ 骏成科技 ・ 瑜欣电子 ・ 洁雅股份 ・ 军信股份 ・ 青木科技 ・ 粤万年青 ・ 信邦智能 ・ 雅艺科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies